Oceanic Pharmachem Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
as on 30-12-2024
- Paid Up Capital ₹ 2.50 Cr
as on 30-12-2024
- Company Age 27 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 37.00 Cr
as on 30-12-2024
- Satisfied Charges ₹ 2.45 Cr
as on 30-12-2024
- Revenue 1.72%
(FY 2022)
- Profit 24.28%
(FY 2022)
- Ebitda -16.35%
(FY 2022)
- Net Worth 22.79%
(FY 2022)
- Total Assets 39.70%
(FY 2022)
About Oceanic Pharmachem
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 2.50 Cr.
The company currently has active open charges totaling ₹37.00 Cr. The company has closed loans amounting to ₹2.45 Cr, as per Ministry of Corporate Affairs (MCA) records.
Jayesh Shah and Dina Shah serve as directors at the Company.
- CIN/LLPIN
U24100MH1997PTC107746
- Company No.
107746
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 May 1997
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Oceanic Pharmachem?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jayesh Shah  | Director | 02-May-1997 | Current |
Dina Shah  | Director | 02-May-1997 | Current |
Financial Performance of Oceanic Pharmachem.
Oceanic Pharmachem Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 1.72% increase. The company also saw a substantial improvement in profitability, with a 24.28% increase in profit. The company's net worth Soared by an impressive increase of 22.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Oceanic Pharmachem?
In 2022, Oceanic Pharmachem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Oceanic Life Sciences Private LimitedActive 1 year 3 monthsJayesh Shah and Dina Shah are mutual person
- Oceanic R & D Centre Private LimitedActive 1 year 3 months
Jayesh Shah and Dina Shah are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Citi Bank N.A. Creation Date: 28 Jun 2023 | ₹25.00 Cr | Open |
Others Creation Date: 17 Dec 2007 | ₹12.00 Cr | Open |
Icici Bank Limited Creation Date: 20 Aug 2015 | ₹2.45 Cr | Satisfied |
How Many Employees Work at Oceanic Pharmachem?
Oceanic Pharmachem has a workforce of 2 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Oceanic Pharmachem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Oceanic Pharmachem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
